Scientific Advisors

REVA Medical has enlisted the support of prominent interventional cardiologists to serve on its Scientific Advisory Board and help guide the development and introduction of new products.

Gregg W. Stone, MD, FACC, FSCAI is Professor of Medicine at Columbia University and Director of Cardiovascular Research and Education for the Center for Interventional Vascular Therapy at the Columbia Medical Center and the Cardiovascular Research Foundation in New York. His medical practice at the New York-Presbyterian Hospital/Columbia University Medical Center is focused on interventional cardiology. He has served as principal investigator for more than 40 national and international multicenter randomized trials, authored more than 1,000 book chapters, manuscripts and abstracts published in peer-reviewed literature and delivered thousands of lectures around the world. Together with Dr. Martin B. Leon, Dr. Stone is the Director of Transcatheter Cardiovascular Therapeutics (TCT), the world’s largest symposium on interventional cardiology and vascular medicine. Dr. Stone is board certified in interventional cardiology, cardiovascular diseases and internal medicine.

Alexandre A. Abizaid, MD is Chief of Coronary Interventions at Institute Dante Pazzanese of Cardiology in Sao Paulo, Brazil, a Visiting Professor of Medicine at Columbia University and a practicing interventional cardiologist at Albert Einstein Hospital in Sao Paulo. He has served as principal investigator for numerous international trials and authored more than 400 abstracts presented at international meetings. Dr. Abizaid is a member of the Sao Paulo State of Brazil Society of Cardiology and the Latin American Society of Interventional Cardiology, a fellow-trainee of the American College of Cardiology, and certified as a Specialist in Cardiology by the Brazilian Society of Interventional Cardiology.

Dean J. Kereiakes, MD is Medical Director of the Heart and Vascular Center and Carl and Edyth Lindner Center for Research and Education at The Christ Hospital in Cincinnati, and Professor of Clinical Medicine at Ohio State University. Principal investigator for most of the interventional technologies introduced during the past two decades, Dr. Kereiakes has performed more than 25,000 catheterization laboratory procedures, published over 600 journal articles, abstracts and book chapters, and previously served as section editor for Circulation. He is a fellow of the American College of Cardiology and was formerly a member of the Joint American College of Cardiology/American Heart Association Task Force Committees to write guidelines for both coronary angioplasty and unstable angina. Dr. Kereiakes received his medical degree and was valedictorian of his graduating class at the University of Cincinnati. His postgraduate training included an internship and residency at the University of California, San Francisco, senior residency at the Massachusetts General Hospital and chief residency at the University of California, San Francisco.

Alan C. Yeung, MD is the Director of Interventional Cardiology for the Stanford University School of Medicine. His current research interests include methods of assessing vascular endothelial function to better stratify high-risk coronary artery disease patients; structural and functional studies of atherosclerosis in transplant coronary artery disease patients; and the development of novel techniques to deliver drug-imbedded particles into the atherosclerotic wall. He sits on the editorial boards of several major cardiovascular journals and is chairman of the Interventional Cardiology Board of the American Board of Internal Medicine. He received his medical doctorate from Harvard Medical School in Boston and completed his internship and residency at Massachusetts General Hospital and his cardiology fellowship at Brigham and Women’s Hospital in Boston. He is board certified in interventional cardiology, cardiovascular medicine, and internal medicine.